Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.64B P/E - EPS this Y 103.00% Ern Qtrly Grth -
Income -1.48B Forward P/E 3.47 EPS next Y 753.50% 50D Avg Chg -50.00%
Sales 1.29B PEG - EPS past 5Y - 200D Avg Chg -71.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -92.00%
Recommedations 2.50 Quick Ratio 0.73 Shares Outstanding 78.22M 52W Low Chg 3.00%
Insider Own 0.46% ROA -32.71% Shares Float 77.97M Beta 1.64
Inst Own 44.54% ROE -898.20% Shares Shorted/Prior 15.62M/16.33M Price 21.00
Gross Margin -80.53% Profit Margin -114.32% Avg. Volume 6,141,534 Target Price 105.83
Oper. Margin -108.90% Earnings Date Nov 2 Volume 5,273,361 Change -6.42%

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX Chatroom

User Image domenic1 Posted - 4 minutes ago

$NVAX Wait until the Reddit Army comes thru just like in the March of the Wooden Soldiers!

User Image Badwisco0 Posted - 4 minutes ago

$NVAX dead money

User Image upgrayeddd Posted - 23 minutes ago

$NVAX everyone ready to have fun this week while the s+p and NASDAQ test their precovid highs, and it becomes even more apparent no one is taking your vaccine?

User Image stocktargetadvisors Posted - 56 minutes ago

USA stocks with worst weekly price performance on Stock Target Advisor https://www.stocktargetadvisor.com on 2022-09-26 : $TELL, $NVAX, $SHC, $CZR, $PTEN

User Image agandalf Posted - 1 hour ago

$NVAX will be back to $4 next weeks .. today another -20%

User Image LookForArrow Posted - 1 hour ago

$NVAX - Motley Fool journalist have opened an attack on Novavax. Their disclosure statement states that they recommend Moderna.

User Image oliveinvest Posted - 1 hour ago

Bullish outlook? Here's how to sell options to win. A variable return strategy for $NVAX Make up to 44.4% (115.2% annualized) NVAX can fall 42% before you start to lose. Buy 1 $20 call Sell 1 $30 call Sell 2 $12.5 puts Exp 3/17/23 Capital Req. $2423.64 👉🏼Click my profile link to see how its done.

User Image Rvl76 Posted - 1 hour ago

$NVAX is posibble to see capitulation here some day? It´s awful

User Image Glackattack Posted - 1 hour ago

$NVAX In case anyone missed this. management is in clear denial. https://youtu.be/Vlu-KkN7k90

User Image 750cease Posted - 1 hour ago

$NVAX this pos looks like it will bleed to 10-12, so don't bother averaging down till we test all lows of the market. At this point give me $50 next year and im outta here. Cause that 100-150 is out of the question, trust it wouldn't have fell this much, even before the hikes it was falling. Smh

User Image ChartMill Posted - 1 hour ago

$NVAX was analyzed by 14 analysts. The buy consensus is at 77%. So analysts seem to be mildly confident about $NVAX. https://www.chartmill.com/stock/analyzer/stock/NVAX?view=analyst-ratings&utm_source=stocktwits&utm_medium=ANALYST&utm_content=NVAX&utm_campaign=social_tracking

User Image Glackattack Posted - 1 hour ago

$NVAX At this point, what would ignite a short squeeze here? Don't think it will be USA booster approval because boosters are already approved in Europe, Asia, and Australia. All were sell offs. Only thing I can see is a new (and deadly) variant moving this up significantly.

User Image Dreamslayer Posted - 1 hour ago

$NVAX It has been an year since this paper was published and there has been radio silence from the management since then. And they are burning 1/2 Billion every quarter! I am presuming that they plan to go ahead with the Covid-Nanoflu combo vaccine Phase 3 trial slated to start next year and apply for EUA in a couple of years time, instead of applying for EUA of standalone Nanoflu! This is to highlight how incompetent the present management is and how royally screwed we are! Any thoughts? https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00192-4/fulltext

User Image 750cease Posted - 1 hour ago

$NVAX gee what a surprise, every vac stock up except this one, 🤦🏽‍♂️. What a shit show

User Image JJBurch Posted - 1 hour ago

$GOVX The vaccine platform geoVax uses and which is proprietary has already been proven safe and effective with several studies. The Ebola Sudan test is just one of many seeing if the platform works. Preclinical animal show 100% efficacy. To get to Ph1/2 and to EUA may only take one year. Regardless, the platform has been proven and the value here should be $10+ minimum at this stage I believe this is $NVAX 2.0 and will be $20+ THIS year. Or early next. Weeks away at most. COVID, MonkeyPox, Sudan Ebola. ALL

User Image domenic1 Posted - 1 hour ago

$NVAX https://www.dailyo.in/news/ebola-is-back-in-africa-but-do-we-need-to-worry-about-it-becoming-a-pandemic-37421

User Image CalebKing82 Posted - 2 hours ago

$NVAX today no SSR....with SSR already dropped 6%+…cannot imagine without SSR with bad market…

User Image safecapital Posted - 2 hours ago

$nvax Only way this goes to triple digits is if Stan the ceo leaves. He is in denial when the anchor told hime he is late to covid party which was obvious.

User Image kipharm Posted - 2 hours ago

$NVAX FDA needs to approve boosters but the timing is unclear. The next winner in covid vaccine race is based on durability and flu combination which Novavax seems to have an edge.

User Image Glackattack Posted - 2 hours ago

$NVAX Fool says near term is bleak. No shit! But long term is promising. Duh! They are so helpful. https://www.fool.com/investing/2022/09/26/is-there-hope-for-this-struggling-vaccine-stock/

User Image kipharm Posted - 2 hours ago

$NVAX Almost close to the bottom given its approvals and pipelines. Any positive news on booster approvals or covid cases will push this higher. Setup for a spike very soon.

User Image Glackattack Posted - 2 hours ago

$NVAX Here's their current pipeline status. With the exception of COVID boosters and Nanoflu (by itself), everything is at least 3 years out as trial phases take time. Unless you test on 8 mice thought. https://www.novavax.com/science-technology/vaccine-pipeline

User Image SweepCast Posted - 2 hours ago

@SweepCast Unusual Options Observed: $NVAX with our scanner on $23 PUT Expiring: 09-23-2022 worth 42K🐻 ⬅️ Use this in real-time with @SweepCast - See Profile for More Info 🏆

User Image joedaddy1976 Posted - 2 hours ago

$NVAX Is the Ebola vaccine ready to go or is Novavax still in a phase trial? Does anyone know?

User Image Ijsie22 Posted - 2 hours ago

$NVAX under 20 today

User Image domenic1 Posted - 2 hours ago

$NVAX Will Ebola come to Stan's rescue? Believe it or not but that pathetic schmuck may actually walk away with another financial bonanza. AND this time the dumb-ass may actually pull this off. NVAX has the production capacity to divert from Covid production (or lack of) to Ebola production. This story isn't over yet. Un-f'n-believable!!!!

User Image Sandbluewsun Posted - 3 hours ago

$NVAX Hopefully this is true and what they should be doing everywhere: "Dr Dubovsky and Mr Trizzino spent the week lobbying politicians in Canberra to give Novavax a bigger role in its long term immunisation strategy and met with Health Minister Mark Butler on Wednesday"

User Image allcharts Posted - 5 hours ago

$NVAX NVAX 2022-09-25 Daily Forecast Video: https://www.youtube.com/watch?v=HxHD4Z3e7vU

User Image TheCamMan2020 Posted - 8 hours ago

$NVAX 18.70 tomorrow Mark it

User Image chrisbever Posted - 9 hours ago

$NVAX loading up is the only solution to shorts. Naked shorting and hit journals, intentional delay by fda and in competent management has caused this pathetic share price. I think Fuji needs to be investigated for their role in manufacturing delay. How low is low? I never thought this will come this low. Hope it’s going back up from here

Analyst Ratings
JP Morgan Underweight Sep 22, 22
Cowen & Co. Outperform Aug 9, 22
Cantor Fitzgerald Overweight Jun 8, 22
B of A Securities Underperform May 20, 22
B. Riley Securities Buy Apr 26, 22
HC Wainwright & Co. Buy Mar 3, 22
Cowen & Co. Outperform Jan 21, 22
JP Morgan Neutral Dec 21, 21
Cantor Fitzgerald Overweight Jun 15, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
YOUNG JAMES F Director Director Mar 31 Sell 74.21 12,500 927,625 62,590 04/04/22
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Option 19.08 5,000 95,400 7,760 12/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Sell 197.3 5,000 986,500 2,760 12/03/21
Glenn Gregory M President, R&D President, R&D Nov 23 Option 19.08 8,250 157,410 12,311 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 23 Sell 200.02 8,250 1,650,165 4,061 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 02 Option 19.08 8,250 157,410 12,311 11/04/21
Glenn Gregory M President, R&D President, R&D Nov 02 Sell 186.83 8,250 1,541,348 4,061 11/04/21
Glenn Gregory M President, R&D President, R&D Oct 26 Sell 132.97 10,334 1,374,112 4,061 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 26 Option 10.33 11,712 120,985 5,439 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 19 Option 19.08 8,250 157,410 12,311 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 19 Sell 166.54 8,250 1,373,955 4,061 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 12 Option 19.08 8,250 157,410 12,311 10/14/21
Glenn Gregory M President, R&D President, R&D Oct 12 Sell 164.07 8,250 1,353,578 4,061 10/14/21
Glenn Gregory M President, R&D President, R&D Jun 17 Option 22.5 10,535 237,038 7,630 06/17/21
Glenn Gregory M President, R&D President, R&D Jun 17 Sell 191.31 8,127 1,554,776 2,811 06/17/21
Glenn Gregory M President, R&D President, R&D Apr 19 Option 61.73 10,531 650,079 7,630 04/19/21
MCMANUS MICHAEL A JR Director Director Mar 23 Sell 220.99 4,000 883,960 5,951 03/23/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Option 21.38 3,404 72,778 670 03/09/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Sell 163.31 3,211 524,388 287 03/09/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Option 26.71 15,022 401,238 15,297 02/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Sell 241.28 15,022 3,624,508 275 02/03/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Option 23.25 13,756 319,827 1,436 01/07/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Sell 114.35 17,913 2,048,352 287 01/07/21
Erck Stanley C President and CEO President and CEO Nov 18 Option 32.7 52,317 1,710,766 72,811 11/18/20
Erck Stanley C President and CEO President and CEO Nov 18 Sell 90.33 52,316 4,725,704 20,495 11/18/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Oct 01 Sell 111.32 2,250 250,470 5,087 10/01/20
Erck Stanley C President and CEO President and CEO Oct 01 Sell 111.71 12,233 1,366,548 20,494 10/01/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Option 5.95 24,750 147,262 43,054 09/30/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Sell 110.91 42,779 4,744,618 275 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Option 5.95 25,000 148,750 46,510 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Sell 110.91 44,949 4,985,295 1,561 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Option 5.95 29,600 176,120 53,008 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Sell 110.86 43,321 4,802,567 7,337 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Option 5.95 50,000 297,500 74,606 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Sell 110.91 29,112 3,228,813 32,727 09/30/20